Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve the financial results of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience has postponed its Board meeting, originally scheduled for July 29, 2025, to August 1, 2025, citing unforeseen and unavoidable circumstances. The meeting will now consider and approve the financial results for the period ended March 31, 2025. The trading window for designated persons remains closed until August 3, 2025. The CFO, Venkata Sathya Murali Dokka, has signed the intimation. No financial figures or business details have been disclosed in this filing.
This is a routine procedural update and does not directly affect shareholders, though the vague reason for postponement may cause minor investor curiosity. Investors should watch for the financial results announcement on August 1, 2025 for any meaningful business signals.